CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Short Interest Down 98.9% in November

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) was the target of a significant decline in short interest in November. As of November 15th, there was short interest totalling 4,900 shares, a decline of 98.9% from the October 31st total of 429,500 shares. Based on an average daily volume of 40,600 shares, the short-interest ratio is currently 0.1 days.

CSPC Pharmaceutical Group Trading Up 3.1 %

Shares of CSPCY stock traded up C$0.08 during trading hours on Thursday, reaching C$2.64. The company’s stock had a trading volume of 5,526 shares, compared to its average volume of 40,428. CSPC Pharmaceutical Group has a fifty-two week low of C$2.25 and a fifty-two week high of C$3.82. The firm’s 50 day simple moving average is C$2.93 and its 200-day simple moving average is C$2.97.

CSPC Pharmaceutical Group Increases Dividend

The business also recently announced a dividend, which will be paid on Thursday, December 5th. Investors of record on Friday, November 1st will be given a dividend of $0.0575 per share. The ex-dividend date of this dividend is Friday, November 1st. This is an increase from CSPC Pharmaceutical Group’s previous dividend of $0.06.

CSPC Pharmaceutical Group Company Profile

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.